Navigation Links
Angiotensin-II-receptor blockers - Treat kidney failure

Drugs used to treat high blood pressure have been found to also help slow the progress of kidney failure. Three separate drug trials reveal that the angiotensin-II-receptor blockers, which include losartan and irbesartan, can be used to treat kidney failure, one of the commonest complications in diabetes. //

In the first trial, carried out by doctors in Boston, USA, 1500 patients with type 2 diabetes and kidney disease were given either losartan or placebo. After three years of follow up, the losartan group had a 28 per cent lower risk of end-stage kidney disease. This is equivalent to delaying the need for dialysis or transplantation by two years.

The second trial involved researchers in Chicago who found that the progression of kidney disease or death was reduced by around 20 per cent in patients on irbesartan. Even those with advanced disease could benefit, although the treatment is best started early on. A final study of irbesartan on diabetic patients with early signs of kidney disease showed the condition was less likely to progress than in similar patients on placebo. The trials offer new hope to people with diabetes, for there has been no treatment for kidney complications till now. They also underline the need for the earliest possible diagnosis of kidney disease in people with diabetes.


'"/>




Page: 1

Related medicine news :

1. Calcium-blocker delays atherosclerosis than beta-blockers
2. Evidence against use of Beta blockers as first choice in the treatment of primary hypertension
3. Alpha-blockers call for modification in cataract surgery
4. Advances in Treatment of Cataracts
5. Recommendations for Treatment of Blood Pressue
6. New FDA Approved Drug To Treat Migraine
7. Treatment for Menieres disease
8. Treatment for pre-menstrual syndrome is ineffective
9. Cipro Has Cheaper Cousins to Treat Anthrax
10. Better Treatment for obesity
11. Gene Treatment for Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Angiotensin receptor blockers Treat kidney failure

(Date:7/31/2014)... NV (PRWEB) July 31, 2014 Weblify has ... after 4 years of development and testing. The result ... monetized websites in as little as 5 minutes without knowing ... full Weblify review , Shane Michaels, an SEO expert, agrees ... quickly. “I’ve seen a lot of web site builders ...
(Date:7/31/2014)... Jeremiah’s Tavern joins ... to create a unique atmosphere and highlight their ... reclaimed barn siding on the exterior ... softwoods flowing throughout the interior as flooring. In ... company New Energy Works Timberframers add ...
(Date:7/31/2014)... Ticket Down is a dependable source ... at the Sun Life Stadium in Miami on Monday, August ... underway. Residents and diehard soccer fans from the Miami, Florida ... International Champions Cup final in person at Sun Life Stadium. ... have been split into two groups where they will then ...
(Date:7/31/2014)... Dr. Mohebi was asked about his experience ... of traveling and sharing what we learned through research ... We are now witnessing results that we never thought ... pleasure to communicate this knowledge to our international colleagues.” ... performing FUE transplantation helped inspire many other doctors to ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 A program ... is coming to the University of Colorado Anschutz ... destination weight loss boot camp and transformation program. ... between AHWC and Eyeworks USA, is an evidenced-based program ... for ABC by Eyeworks USA. This season, the show ...
Breaking Medicine News(10 mins):Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 3Health News:Popular Tavern Restaurant Features Pioneer Millworks’ Reclaimed Wood in New Locations 2Health News:Guinness International Champions Cup Finals Tickets in Miami, FL Available at Ticket Down 2Health News:Guinness International Champions Cup Finals Tickets in Miami, FL Available at Ticket Down 3Health News:Los Angles Hair Transplant Surgeon, Dr. Parsa Mohebi Inspires Doctors at Global Conferences to Adopt His Novel Method in FUE Hair Transplantation 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 2Health News:"Extreme Weight Loss: Destination Boot Camp" Comes to Colorado - The CU Anschutz Health and Wellness Center Begins Transformational Program 3
... at work are more likely than long hours, night ... interfere with their sleep. , That,s the conclusion of ... the annual meeting of the Population Association of America. ... approximately 2,300 U.S. adults that monitored the same workers ...
... Antibiotic-Resistant Pathogens Earn Avelox Gold Standard Status Through ... According to a New Report from Decision Resources, ... one of the,world,s leading research and advisory firms ... therapy,s overall clinical efficacy,(defined as cure or improvement ...
... Bionovo Inc.,(Nasdaq: BNVI ) announced today the appointment ... Directors. Dr. Baxter has extensive experience in,academic research as ... in advancing endocrine drugs., "We are very excited ... our,clinical trial programs," said Isaac Cohen, O.M.D., Bionovo,s Chairman ...
... April 17 Eisai Corporation of,North America today ... President of U.S. Corporate Communications. In this newly ... and coordinating,all of Eisai,s corporate communications strategies and ... to Eisai more than 22 years of global ...
... BERKELEY, Calif., April 17 Losing your home to,foreclosure ... loved one. And with so,many Americans facing this dreaded ... in default, according to USA TODAY (Nov. 11,2007) -- ... as,the financial and practical ones., In her seminal ...
... a life,sciences company based in Shanghai, China and ... made several executive management appointments to,build out its ... has joined ProGenTech as its Vice President for ... the global R&D programs,and have accountability for the ...
Cached Medicine News:Health News:U-M study: Work hassles hamper sleep 2Health News:Bayer/Schering-Plough/Shionogi's Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia 2Health News:John D. Baxter, M.D. Joins Bionovo's Board of Directors 2Health News:John D. Baxter, M.D. Joins Bionovo's Board of Directors 3Health News:Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications 2Health News:Nolo.com Adds Up the Emotional Costs of Foreclosure With the Five Stages of Foreclosure Grief 2Health News:Nolo.com Adds Up the Emotional Costs of Foreclosure With the Five Stages of Foreclosure Grief 3Health News:ProGenTech Limited Appoints Executive Management Team 2
(Date:7/31/2014)... VALLEJO, Calif. , July 31, 2014 ... announce it has been selected as the recipient of ... Foundation, which will allow the University to increase research ... is about creating state-of-the-art technology for the study of ... that enhance the diverse needs and interests of our ...
(Date:7/31/2014)... 31, 2014 For its innovative modular Biomedical ... , Art,s-Way Scientific has earned a Modular Building Institute ... in over 30 categories, MBI,s contest is the commercial ... include building manufacturers, dealers, and product and service providers. ... the capability of our team," said Dan Palmer ...
(Date:7/31/2014)... , July 31, 2014 AFFiRiS AG ... York results of AFF008, a Phase I clinical ... the first therapy against the protein alpha-synuclein, a promising Parkinson,s ... J. Fox Foundation for Parkinson,s Research (MJFF) supported the study ... press conference on the impact a disease-modifying therapy would have ...
Breaking Medicine Technology:Touro University California Garners Grant From Long Foundation 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4
... a commercial stage private oncology company, announced today ... executives to its Global Commercialization Team.  The Global ... new tumor treating fields (TTF) cancer therapy to ... has joined Novocure as chief commercial officer responsible ...
... (OTCBB: POSC), a leading molecular imaging company specializing in ... today that on December 12, 2011, the Company,s Positron ... approval for sale in Canada. The ... the Attrius systems manufacturer, Neusoft Positron Medical Systems. NPMS ...
Cached Medicine Technology:Novocure Adds Three Senior Oncology Executives to its Global Management Team 2Novocure Adds Three Senior Oncology Executives to its Global Management Team 3Novocure Adds Three Senior Oncology Executives to its Global Management Team 4Positron's Attrius Receives Health Canada Approval 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: